Literature DB >> 4147213

Clinical assessment of bronchodilator drugs delivered by aerosol.

G M Shenfield, J W Paterson.   

Abstract

Mesh:

Substances:

Year:  1973        PMID: 4147213      PMCID: PMC470002          DOI: 10.1136/thx.28.2.124

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  10 in total

1.  PATTERNS OF RESPONSE TO BRONCHODILATOR IN YOUNG PATIENTS WITH ASTHMA.

Authors:  M C PAIN; J READ
Journal:  Australas Ann Med       Date:  1963-08

2.  A comparison of spirometric and peak expiratory flow measurements in men with and without chronic bronchitis.

Authors:  A S FAIRBAIRN; C M FLETCHER; C M TINKER; C H WOOD
Journal:  Thorax       Date:  1962-06       Impact factor: 9.139

3.  The response to bronchodilators in intrinsic asthma.

Authors:  K M HUME; E RHYS JONES
Journal:  Q J Med       Date:  1961-04

4.  Forced expiratory volume before and after isoprenaline.

Authors:  K M HUME; B GANDEVIA
Journal:  Thorax       Date:  1957-09       Impact factor: 9.139

5.  Trial of bronchodilator drugs given by metered aerosol with a comparison of two bedside methods of estimating airway resistance.

Authors:  B I Hoffbrand; M I Hoffbrand; I D Hill; P J Heaf
Journal:  Br Med J       Date:  1966-04-23

6.  Isoprenaline resistance and the use of pressurised aerosols in asthma.

Authors:  J W Paterson; M E Conolly; D S Davies; C T Dollery
Journal:  Lancet       Date:  1968-08-24       Impact factor: 79.321

7.  Comparison of cardiorespiratory effects of isoprenaline and salbutamol in patients with bronchial asthma.

Authors:  D A Warrell; D G Robertson; J N Howes; M E Conolly; J W Paterson; L J Beilin; C T Dollery
Journal:  Br Med J       Date:  1970-01-10

8.  Spirometric study of the bronchodilating effects of hydroxyphenylorciprenaline (Th 1165 a) in various forms in a group of 124 coal miners suffering from bronchospasm.

Authors:  A Minette
Journal:  Respiration       Date:  1970       Impact factor: 3.580

9.  Trial of new bronchodilator, terbutaline, in asthma.

Authors:  B J Freedman
Journal:  Br Med J       Date:  1971-03-20

10.  Effects of salbutamol and isoprenaline-phenylephrine in reversible airways obstruction.

Authors:  R J Alliott; B D Lang; D R Rawson; W J Leckie
Journal:  Br Med J       Date:  1972-02-26
  10 in total
  26 in total

1.  Comparative potencies and beta2-adrenoreceptor selectivities of rimiterol and salbutamol aerosols.

Authors:  G E Marlin; B J Hartnett; N Berend
Journal:  Br J Clin Pharmacol       Date:  1977-02       Impact factor: 4.335

Review 2.  Rimiterol: a review of its pharmacological properties and therapeutic efficacy in asthma.

Authors:  R M Pinder; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-08       Impact factor: 9.546

3.  The clinical pharmacology of salmefamol.

Authors:  M E Evans; G M Shenfield; J W Paterson
Journal:  Br J Clin Pharmacol       Date:  1974-10       Impact factor: 4.335

4.  Assessment of combined oral theophylline and inhaled beta-adrenoceptor agonist bronchodilator therapy.

Authors:  G E Marlin; B J Hartnett; N Berend; N B Hacket
Journal:  Br J Clin Pharmacol       Date:  1978-01       Impact factor: 4.335

5.  The acute effects of the administration of rimiterol aerosol in asthmatic children.

Authors:  M I Blackhall; B Macartney; S R O'Donnell
Journal:  Br J Clin Pharmacol       Date:  1978-07       Impact factor: 4.335

6.  A cumulative dose comparison between salbutamol and fenoterol metered dose aerosols in asthmatic patients.

Authors:  D Bellamy; A Penketh
Journal:  Postgrad Med J       Date:  1987-06       Impact factor: 2.401

Review 7.  Combination bronchodilator therapy.

Authors:  G M Shenfield
Journal:  Drugs       Date:  1982-11       Impact factor: 9.546

8.  A comparative study of atropine methonitrate, salbutamol, and their combination in airways obstruction.

Authors:  R J Pierce; C J Allen; A H Campbell
Journal:  Thorax       Date:  1979-02       Impact factor: 9.139

Review 9.  Fenoterol: a review of its pharmacological properties and therapeutic efficacy in asthma.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-01       Impact factor: 9.546

10.  Salmefamol orally in asthmatics - two doses compared.

Authors:  R W Sillett; C H Dash; M W McNicol
Journal:  Eur J Clin Pharmacol       Date:  1976-02-06       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.